Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-23

Clinical Trial Update: 5-day Defibrotide Treatment for Hepatic SOS/VOD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 5-day defibrotide treatment for Sinusoidal Obstruction Syndrome/Veno-occlusive Disease (related to bone marrow transplant complications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Defibrotide (defibrotide)

Snippet

Sponsor: Loyola University | Conditions: Sinusoidal Obstruction Syndrome, Veno-occlusive Disease | Phase 2 | Status: UNKNOWN